Clinical Trial Update: Evaluation of Intrafractional Motion of Liver Tumors Using Markers [NA]

View source ↗

Summary

Clinical trial NCT02095236 evaluating intrafractional motion of liver tumors using markers has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Tumor, Effects of; Movement | NA | Status: WITHDRAWN